E-64

E-64

66701-25-5

C15H27N5O5;

; L-TRANS-3-CARBOXYOXIRAN-2-CARBONYL-L-LEUCYLAGMATINE; Oxiranecarboxylic acid, 3-(((1-(((4-((aminoiminomethyl)amino)butyl)amino)carbonyl)-3-methylbutyl)amino)carbonyl)-, (2S-(2-alpha,3-beta(R*)))-; 5-18-07-00006 (Beilstein Handbook Reference); Oxiranecarboxylic acid, 3-(((1-(((4-((aminoiminomethyl)amino)butyl)amino)carbonyl)-3-methylbutyl)amino)carbonyl)-, (2S-(2alpha,3beta(R*)))-; Thiol protease inhibitor; E-64 PROTEASE INHIBITOR; (2S, 3S)-TRANS-EPOXY SUCCINYL-L-LEUCYLAMIDO-(4-GUANIDINO) BUTANE; E 64 (proteinase inhibitor); E 64; L-TRANS-EPOXYSUCCINYL-LEU-AGMATINE; BRN 1405664; E-64; L-TRANS-EPOXYSUCCINYL-LEUCYLAMIDE-(4-GUANIDO)-BUTANE; Proteinase inhibitor E 64; UNII-R76F7856MV; E64; EPOXYSUCCINYL-L-LEUCYLAMIDO-(4-GUANIDINO)BUTANE; L-TRANS-EPOXYSUCCINYL-LEU-4-GUANIDINOBUTYLAMIDE; E-64 HEMIHYDRATE; (L-3-TRANS-CARBOXYOXIRANE-2-CARBONYL)-L-LEUCYLAGMATINE HEMIHYDRATE

357.41

O1[C@@H]([C@H]1C(=O)O)C(N[C@H](C(=O)NCCCCNC(=N)N)CC(C)C)=O

LTLYEAJONXGNFG-DCAQKATOSA-N

1S/C15H27N5O5/c1-8(2)7-9(20-13(22)10-11(25-10)14(23)24)12(21)18-5-3-4-6-19-15(16)17/h8-11H,3-7H2,1-2H3,(H,18,21)(H,20,22)(H,23,24)(H4,16,17,19)/t9-,10-,11-/m0/s1

H2O: 20 mg/mL, clear, colorless

2-8°C